Bio Green Med Solution, Inc.

Bio Green Med Solution, Inc.

3.00
USD
+0.60
(+25.13%)
Nov 18Next Earn

Important Dates

Bio Green Med Solution Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

Earnings Date11/18/2026

Financial Position

As of June 30, 2026, Bio Green Med Solution Inc. maintains a current ratio of 8.63, meaning it holds 8.6x the short-term assets needed to cover near-term liabilities.

Current Ratio8.63
Quick Ratio7.03

Financial Efficiency

USD

Over the twelve months ended June 30, 2026, Bio Green Med Solution Inc. posted a negative return on equity (ROE) of -42.31, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -35.92, reflecting losses generated across the asset base. The company generates approximately 155,083.33 in revenue per employee across its workforce of 12.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-42.31
Return on Assets (ROA)-35.92
Revenue Per Employee155,083.33
Employee Count12.00

Taxes

USD

Over the twelve months ended June 30, 2026, Bio Green Med Solution Inc. recorded 44,000.00 in income tax expense. The company reported a pretax loss of -2.16M and -2.20M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax44,000.00

Stock Price Statistics

USD

As of the close on October 21, 2026, Bio Green Med Solution Inc.'s stock has declined approximately 47.37% over the past 52 weeks.

52-Week Price Change-47.37%
50-Day Moving Average1.79

Income Statement

USD

These figures cover the twelve months ended June 30, 2026. EBITDA reached -2.73M, while operating income came in at -2.74M.

Revenue1.86M
Gross Profit360,000.00
Operating Income-2.74M
Pretax Income-2.16M
Net Income-2.20M
EBITDA-2.73M
EBIT-2.74M

Balance Sheet

USD

As of June 30, 2026, Bio Green Med Solution Inc. holds 3.79M in cash and equivalents against - - in total debt, resulting in a net debt position of -3.79M. Total book value stands at 7.16M, with working capital of 5.28M providing operational flexibility.

Cash & Cash Equivalents3.79M
Net Debt-3.79M
Equity (Book Value)7.16M
Working Capital5.28M

Cash Flow

USD

Bio Green Med Solution Inc. produced -1.10M in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-1.10M
Capital Expenditures-1,000.00
Free Cash Flow-1.10M

Margins

Over the twelve months ended June 30, 2026, Bio Green Med Solution Inc. posted a gross margin of 19.34, reflecting its pricing power and cost economics. The operating margin of -147.13 and net profit margin of -118.27 provide insight into operational efficiency.

Gross Margin19.34
Operating Margin-147.13
Pretax Margin-115.91
Profit Margin-118.27
EBITDA Margin-146.86

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 0.88 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Payout Ratio0.88